Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Peripodial adherens junctions regulate Ajuba-Yorkie signaling to preserve fly eye morphology. | Biol Open | 2023 | 36912729 | PubTator, text mining | PubMed |
| Metabolic pathways of potential miRNA biomarkers derived from liquid biopsy in epithelial ovarian cancer. | Oncol Lett | 2023 | 36909377 | PubTator, text mining | PubMed |
| An EMT-based gene signature enhances the clinical understanding and prognostic prediction of patients with ovarian cancers. | J Ovarian Res | 2023 | 36907877 | PubTator, text mining | PubMed |
| Endothelial plasticity across PTEN and Hippo pathways: A complex hormetic rheostat modulated by extracellular vesicles. | Transl Oncol | 2023 | 36905871 | PubTator, text mining | PubMed |
| Natural Products in Precision Oncology: Plant-Based Small Molecule Inhibitors of Protein Kinases for Cancer Chemoprevention. | Nutrients | 2023 | 36904191 | PubTator, text mining | PubMed |
| LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features. | Cells | 2023 | 36899941 | PubTator, text mining | PubMed |
| Phosphorylation-linked complex profiling identifies assemblies required for Hippo signal integration. | Mol Syst Biol | 2023 | 36896621 | PubTator, text mining | PubMed |
| Therapeutic potential of exosome-based personalized delivery platform in chronic inflammatory diseases. | Asian J Pharm Sci | 2023 | 36896446 | PubTator, text mining | PubMed |
| Hippo pathway and Bonus control developmental cell fate decisions in the Drosophila eye. | Dev Cell | 2023 | 36868234 | PubTator, text mining | PubMed |
| Oncogenic YAP mediates changes in chromatin accessibility and activity that drive cell cycle gene expression and cell migration. | Nucleic Acids Res | 2023 | 36864753 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway. | Cancer Commun (Lond) | 2023 | 36860124 | PubTator, text mining | PubMed |
| Angiotensin receptor blockers retard the progression and fibrosis via inhibiting the viability of AGTR1+ CAFs in intrahepatic cholangiocarcinoma. | Clin Transl Med | 2023 | 36855786 | PubTator, text mining | PubMed |
| DEPDC1 and KIF4A synergistically inhibit the malignant biological behavior of osteosarcoma cells through Hippo signaling pathway. | J Orthop Surg Res | 2023 | 36849972 | PubTator, text mining | PubMed |
| Polyacetylene Isomers Isolated from Bidens pilosa L. Suppress the Metastasis of Gastric Cancer Cells by Inhibiting Wnt/β-Catenin and Hippo/YAP Signaling Pathways. | Molecules | 2023 | 36838824 | PubTator, text mining | PubMed |
| The Genes-Stemness-Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints. | Int J Mol Sci | 2023 | 36834912 | PubTator, text mining | PubMed |
| Conjugated Bile Acids Promote Lymphangiogenesis by Modulation of the Reactive Oxygen Species-p90RSK-Vascular Endothelial Growth Factor Receptor 3 Pathway. | Cells | 2023 | 36831193 | PubTator, text mining | PubMed |
| Functional Relevance of the Long Intergenic Non-Coding RNA Regulator of Reprogramming (Linc-ROR) in Cancer Proliferation, Metastasis, and Drug Resistance. | Noncoding RNA | 2023 | 36827545 | PubTator, text mining | PubMed |
| Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma. | Medicine (Baltimore) | 2023 | 36820554 | PubTator, text mining | PubMed |
| The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis. | Front Med (Lausanne) | 2023 | 36817783 | PubTator, text mining | PubMed |
| Eye disease drug as a potential cure for COVID-19: one foot-in-the-door. | Eye (Lond) | 2023 | 36813997 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=25